Alphatec reported 88.2 percent to 90.2 percent year-over-year revenue growth in the second quarter on July 12.
Spinal Tech
The FDA raised safety concerns with NuVasive's stainless steel Precice devices and recommended surgeons stop implanting them.
Clinical trial results of the iFuse-3D implant system demonstrated significant improvements in sacroiliac joint pain, function and quality of life at 24 months.
The FDA provides "breakthrough device" designation to products that are deemed effective to treat certain diseases and conditions. The designation speeds up the development, assessment and review for products.
Zimmer Biomet's spine spinoff, NewCo, is expected to begin operations in mid-2022, with former Medtronic executive Vafa Jamali appointed CEO of the new independent company.
Advertisement
From a multimillion-dollar acquisition to advances in several innovations, here are five notes on SeaSpine so far in 2021:
The FDA has provided clearance for SeaSpine's 7D percutaneous spine module for minimally invasive surgery.
Conformis has entered into a settlement with Stryker to resolve a patent dispute against Wright Medical, which Stryker acquired for $4 billion in November.
Spine device company Camber Spine named Greg Reiswig as vice president of sales in the Western U.S., according to a July 7 news release.
A merger to accelerate robotic surgery, and four more updates from spine and orthopedic device companies in the last week: